↓ Skip to main content

Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia

Overview of attention for article published in Clinical Epigenetics, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users
patent
1 patent

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
62 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
Published in
Clinical Epigenetics, November 2015
DOI 10.1186/s13148-015-0151-8
Pubmed ID
Authors

Cheng Zhang, Jiang F. Zhong, Andres Stucky, Xue-Lian Chen, Michael F. Press, Xi Zhang

Abstract

Acute lymphoblastic leukemia (ALL) has been generally considered a genetic disease (disorder) with an aggressive tumor entity of highly proliferative malignant lymphoid cells. However, in recent years, significant advances have been made in the elucidation of the ALL-associated processes. Thus, we understand that histone acetylation is involved in the permanent changes of gene expression controlling ALL developmental outcomes. In this article, we will focus on histone acetylation associated with ALL, their implications as biomarkers for prognostic, and their preclinical and clinical applications.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 2%
Unknown 61 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 29%
Student > Bachelor 12 19%
Student > Master 11 18%
Researcher 6 10%
Student > Doctoral Student 2 3%
Other 3 5%
Unknown 10 16%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 29%
Agricultural and Biological Sciences 9 15%
Medicine and Dentistry 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Chemistry 4 6%
Other 6 10%
Unknown 15 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2022.
All research outputs
#5,487,063
of 23,041,514 outputs
Outputs from Clinical Epigenetics
#331
of 1,266 outputs
Outputs of similar age
#68,749
of 285,928 outputs
Outputs of similar age from Clinical Epigenetics
#13
of 27 outputs
Altmetric has tracked 23,041,514 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,266 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,928 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.